Fifteen Years of Gene Therapy Based on Chimeric Antigen Receptors: “Are We Nearly There Yet?”-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fifteen Years of Gene Therapy Based on Chimeric Antigen Receptors: “Are We Nearly There Yet?”

Published:2009-11 Issue:11 Volume:20 Page:1229-1239
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Dotti Gianpietro¹²³,Savoldo Barbara¹⁴,Brenner Malcolm¹²⁴

Affiliation:

1. Center for Cell and Gene Therapy, Baylor College of Medicine, Methodist Hospital, and Texas Children's Hospital, Houston, TX 77030.

2. Department of Medicine, Baylor College of Medicine, Methodist Hospital, and Texas Children's Hospital, Houston, TX 77030.

3. Department of Immunology, Baylor College of Medicine, Methodist Hospital, and Texas Children's Hospital, Houston, TX 77030.

4. Department of Pediatrics, Baylor College of Medicine, Methodist Hospital, and Texas Children's Hospital, Houston, TX 77030.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2009.142

Reference90 articles.

1. IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients

2. Regression of Experimental Medulloblastoma following Transfer of HER2-Specific T Cells

3. IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation

4. Interleukin-21: biology and application to cancer therapy

5. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Trends and Innovative Approaches in Cancer Immunotherapy;AAPS PharmSciTech;2024-07-24

2. The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review;Frontiers in Immunology;2024-05-10

3. CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy;Frontiers in Immunology;2024-04-11

4. Modulating Cholesterol Metabolism via ACAT1 Knockdown Enhances Anti-B-Cell Lymphoma Activities of CD19-Specific Chimeric Antigen Receptor T Cells by Improving the Cell Activation and Proliferation;Cells;2024-03-21

5. CAR-T treatment for cancer: prospects and challenges;Frontiers in Oncology;2023-12-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3